Estrella Immunopharma, Inc. (ESLA)

NASDAQ: ESLA · IEX Real-Time Price · USD

1.090

-0.020 (-1.80%)

At close: Jul 2, 2024, 4:00 PM

1.040

-0.050 (-4.59%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Estrella Immunopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021
Market Capitalization	40	63	60	-
Market Cap Growth	-26.65%	5.34%	-	-
Enterprise Value	35	61	61	0
PE Ratio	-	-5.70	-60.43	-
PB Ratio	4.67	-5.40	-26.68	-
P/FCF Ratio	-2.87	-47.46	-57.66	-
P/OCF Ratio	-2.87	-47.46	-57.66	-
EV/EBITDA Ratio	-6.66	-5.46	-66.25	-
EV/EBIT Ratio	-6.68	-5.46	-66.25	-0.23
EV/FCF Ratio	-2.57	-45.40	-58.10	-
Debt / Equity Ratio	-	-	-0.22	8.73
Debt / EBITDA Ratio	-	-	-0.54	-
Debt / FCF Ratio	-	-	-0.48	-
Quick Ratio	34.13	0.28	0.04	0.05
Current Ratio	62.34	0.28	0.05	0.06
Return on Equity (ROE)	-153.60%	177.20%	62.00%	-
Return on Assets (ROA)	-50.30%	-72.30%	-3.80%	-
Return on Capital (ROIC)	-71.72%	94.65%	89.33%	-365.70%
Earnings Yield	-15.36%	-17.53%	-1.65%	-
FCF Yield	-39.90%	-2.11%	-1.73%	-
Buyback Yield / Dilution	-10431.23%	77.96%	-476.29%	-
Total Shareholder Return	-10431.23%	77.96%	-476.29%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).